Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × erdafitinib × Clear all

Sponsor

Conditions

Wilms Tumor 2 Urothelial Cancer 2 Rhabdoid Tumor 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Central Nervous System Neoplasms 2 Xanthogranuloma, Juvenile 1 Urinary Bladder Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Osteosarcoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Myeloma 1 Malignant Solid Neoplasm 1 Lymphoma 1 Histiocytic Sarcoma 1 Familial ependymoma 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

vandetanib 7 Sorafenib 6 Magnetic Resonance Spectroscopy 6 lenvatinib 5 cabozantinib 5 Sunitinib 4 Iodine-131 4 selpercatinib 3 AZD 6244 3 trametinib 2 tipifarnib 2 durvalumab 2 dabrafenib 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Thyrotropin Alfa 2 Paclitaxel 2 Nivolumab 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Everolimus 2 Bortezomib 2 Axitinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 tremelimumab 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡